# Dear Health Care Provider Letters: Improving Communication of Important Safety Information - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/dear-health-care-provider-letters-improving-communication-of-important-safety-information/a3ea6356-848d-4286-86e9-8ac6013377e1

> FDA guidance document: Dear Health Care Provider Letters: Improving Communication of Important Safety Information. Issue date: January 02, 2014. Get complete insights and analysis.

---

## Details

- Title: Dear Health Care Provider Letters: Improving Communication of Important Safety Information
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2014-01-02
- Last Changed: 2023-04-24
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2010-D-0319">FDA-2010-D-0319</a>

## Related Documents

- [Expedited Programs for Serious Conditions | Drugs and Biologics](https://www.globalkeysolutions.net/guidances/guidance-document/expedited-programs-for-serious-conditions-drugs-and-biologics/d49c172d-43db-4e76-a0fd-1f51de9ecff3)
- [CMC Postapproval Manufacturing Changes To Be Documented in Annual Reports](https://www.globalkeysolutions.net/guidances/guidance-document/cmc-postapproval-manufacturing-changes-to-be-documented-in-annual-reports/67341cfe-8a48-4fc7-9817-6f9ed89768cf)
- [Radioactive Drug Research Committee: Human Research Without An Investigational New Drug Application](https://www.globalkeysolutions.net/guidances/guidance-document/radioactive-drug-research-committee-human-research-without-an-investigational-new-drug-application/f573b8cb-8d40-4beb-818f-4d2e16361206)